REGENERON PHARMACEUTICALS, INC. PP&E Net 2009-2022 | REGN
Beta
What is REGENERON PHARMACEUTICALS, INC.'s current pp&e net?
REGENERON PHARMACEUTICALS, INC. (REGN) annual pp&e net for 2021 was $3.48B, a 8.09% increase from 2020. REGENERON PHARMACEUTICALS, INC. pp&e net for the quarter ending September 30, 2022 was $3.70B.
What was REGENERON PHARMACEUTICALS, INC.'s pp&e net in 2020?
REGENERON PHARMACEUTICALS, INC. annual pp&e net for 2020 was $3.22B, a 11.46% increase from 2019.
What was REGENERON PHARMACEUTICALS, INC.'s pp&e net in 2019?
REGENERON PHARMACEUTICALS, INC. annual pp&e net for 2019 was $2.89B, a 12.21% increase from 2018.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year pp&e net CAGR?
REGENERON PHARMACEUTICALS, INC. pp&e net grew at a compound annual growth rate (CAGR) of 10.82% from FY2016 to FY2021, going from $2.08B to $3.48B over 5 years.
PP&E Net History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+10.8%
FY2016
$2.08B
→
FY2021
$3.48B
09101112131415161718192021
5 years selected
PP&E Net History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2021 | $3.48B | +8.1% | 10-K |
| FY2020 | $3.22B | +11.5% | 10-K |
| FY2019 | $2.89B | +12.2% | 10-K |
| FY2018 | $2.58B | +9.2% | 10-K |
| FY2017 | $2.36B | +13.2% | 10-K |
| FY2016 | $2.08B | +30.7% | 10-K |
| FY2015 | $1.59B | +63.6% | 10-K |
| FY2014 | $974.3M | +84.9% | 10-K |
| FY2013 | $527.0M | +38.7% | 10-K |
| FY2012 | $379.9M | +3.3% | 10-K |
| FY2011 | $368.0M | +5.9% | 10-K |
| FY2010 | $347.4M | +33.8% | 10-K |
| FY2009 | $259.7M | - | 10-K |
Company: REGENERON PHARMACEUTICALS, INC.Ticker: REGNSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →